Calliditas Therapeutics AB (publ) (CALT)
USD 40.0
(-0.1%)
USD 40.0
(-0.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.56 Billion SEK | 31.94% |
| 2022 | 1.18 Billion SEK | 162.76% |
| 2021 | 451.62 Million SEK | 80.54% |
| 2020 | 250.15 Million SEK | 337.87% |
| 2019 | 57.12 Million SEK | 88.91% |
| 2018 | 30.24 Million SEK | 3.88% |
| 2017 | 29.11 Million SEK | -29.89% |
| 2016 | 41.52 Million SEK | 313.51% |
| 2015 | 10.04 Million SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.56 Billion SEK | 0.15% |
| 2024 Q2 | 1.64 Billion SEK | 4.61% |
| 2023 Q2 | 1.2 Billion SEK | 0.46% |
| 2023 FY | 1.56 Billion SEK | 31.94% |
| 2023 Q4 | 1.56 Billion SEK | 24.32% |
| 2023 Q3 | 1.25 Billion SEK | 4.54% |
| 2023 Q1 | 1.19 Billion SEK | 1.06% |
| 2022 Q4 | 1.18 Billion SEK | 49.8% |
| 2022 Q3 | 792.17 Million SEK | 7.46% |
| 2022 Q2 | 737.19 Million SEK | 55.79% |
| 2022 Q1 | 473.19 Million SEK | 4.78% |
| 2022 FY | 1.18 Billion SEK | 162.76% |
| 2021 Q3 | 478.13 Million SEK | 83.3% |
| 2021 Q4 | 451.62 Million SEK | -5.54% |
| 2021 FY | 451.62 Million SEK | 80.54% |
| 2021 Q2 | 260.85 Million SEK | 2.48% |
| 2021 Q1 | 254.55 Million SEK | 1.76% |
| 2020 Q1 | 59.73 Million SEK | 4.56% |
| 2020 Q4 | 250.15 Million SEK | 294.59% |
| 2020 Q3 | 63.39 Million SEK | 2.59% |
| 2020 Q2 | 61.79 Million SEK | 3.46% |
| 2020 FY | 250.15 Million SEK | 337.87% |
| 2019 Q2 | 47.45 Million SEK | 60.37% |
| 2019 Q3 | 30.87 Million SEK | -34.93% |
| 2019 Q4 | 57.12 Million SEK | 85.01% |
| 2019 FY | 57.12 Million SEK | 88.91% |
| 2019 Q1 | 29.58 Million SEK | -2.16% |
| 2018 Q4 | 30.24 Million SEK | 6.99% |
| 2018 FY | 30.24 Million SEK | 3.88% |
| 2018 Q3 | 28.26 Million SEK | -52.36% |
| 2018 Q2 | 59.33 Million SEK | 84.9% |
| 2018 Q1 | 32.08 Million SEK | 10.23% |
| 2017 Q4 | 29.11 Million SEK | 0.0% |
| 2017 FY | 29.11 Million SEK | -29.89% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 FY | 41.52 Million SEK | 313.51% |
| 2015 FY | 10.04 Million SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Agenus Inc. | 462.29 Million USD | -238.689% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -565.667% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -590.265% |
| Acelyrin, Inc. | 86.35 Million USD | -1713.189% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -350.47% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -2432.172% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -16615.523% |
| IO Biotech, Inc. | 17.55 Million USD | -8818.563% |
| Ardelyx, Inc. | 130.76 Million USD | -1097.39% |
| Geron Corporation | 146.12 Million USD | -971.495% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -2090.463% |
| Innoviva, Inc. | 568.55 Million USD | -175.391% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -63938.569% |
| ChromaDex Corporation | 26.5 Million USD | -5806.681% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1097.903% |
| Onconetix, Inc. | 23.18 Million USD | -6654.457% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -23349.798% |
| GlycoMimetics, Inc. | 6.9 Million USD | -22585.109% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -5447.166% |
| Vaxcyte, Inc. | 167.44 Million USD | -835.057% |
| Pharming Group N.V. | 244.07 Million USD | -541.506% |
| ContextLogic Inc. | 206 Million USD | -660.069% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -14246.188% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -3160.47% |
| AlloVir, Inc. | 45.01 Million USD | -3378.269% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -23597.244% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -915.773% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -120412.13% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1150.024% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -16418.019% |
| Senti Biosciences, Inc. | 52.57 Million USD | -2878.34% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -79948.211% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -12835.002% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -3249.971% |
| PDS Biotechnology Corporation | 33.25 Million USD | -4607.708% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -5296.323% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -588.405% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -221.771% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -13033.224% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -3185.924% |
| Elevation Oncology, Inc. | 34.28 Million USD | -4467.245% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -475.034% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -117134.592% |
| AbCellera Biologics Inc. | 335.77 Million USD | -366.306% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -44269.315% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1799.413% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -10789.095% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -5591.334% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -23597.244% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -5650.488% |
| ESSA Pharma Inc. | 3.49 Million USD | -44698.604% |
| Vaxxinity, Inc. | 30.94 Million USD | -4959.924% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -23469.818% |
| Structure Therapeutics Inc. | 29.05 Million USD | -5289.635% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -15919.47% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -2176.55% |
| Lantern Pharma Inc. | 2.73 Million USD | -57050.538% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -17394.335% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -38636.838% |
| Opthea Limited | 264.6 Million USD | -491.737% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1125.237% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -933.412% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -5844.58% |
| Molecular Templates, Inc. | 31.17 Million USD | -4923.076% |
| Scopus BioPharma Inc. | 7.45 Million USD | -20904.184% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -216.626% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -3980.325% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -492.21% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -5662.976% |
| ADMA Biologics, Inc. | 193.97 Million USD | -707.184% |
| Alkermes plc | 933.53 Million USD | -67.722% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 61.345% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -48438.536% |
| AnaptysBio, Inc. | 364.28 Million USD | -329.811% |
| Aptorum Group Limited | 5.25 Million USD | -29685.449% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -227.294% |
| Bicycle Therapeutics plc | 224.41 Million USD | -597.709% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1102.475% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1101.304% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -3035.876% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -18680.653% |
| Chimerix, Inc. | 19.74 Million USD | -7829.82% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -1763.403% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -4351.027% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -2057.652% |
| CRISPR Therapeutics AG | 346.76 Million USD | -351.525% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1011.086% |
| Dyadic International, Inc. | 2.34 Million USD | -66793.484% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -9527.639% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1036.243% |
| Fortress Biotech, Inc. | 165.93 Million USD | -843.565% |
| Fortress Biotech, Inc. | 165.93 Million USD | -843.565% |
| GT Biopharma, Inc. | 6.63 Million USD | -23505.352% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -221996.561% |
| ImmuCell Corporation | 18.81 Million USD | -8221.769% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -44271.352% |
| Immix Biopharma, Inc. | 3.72 Million USD | -41969.702% |
| Incyte Corporation | 1.59 Billion USD | 1.666% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -37783.934% |
| Jaguar Health, Inc. | 45.86 Million USD | -3313.733% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -4242.29% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -4040.863% |
| MiMedx Group, Inc. | 96.33 Million USD | -1525.395% |
| MEI Pharma, Inc. | 8.35 Million USD | -18640.192% |
| Mesoblast Limited | 188.79 Million USD | -729.322% |
| Novavax, Inc. | 2.57 Billion USD | 39.13% |
| NextCure, Inc. | 14.99 Million USD | -10340.375% |
| Precigen, Inc. | 41.64 Million USD | -3659.829% |
| PureTech Health plc | 125.58 Million USD | -1146.779% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -973.39% |
| Seer, Inc. | 39.36 Million USD | -3877.5% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -2568.092% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -2022.552% |
| Aptose Biosciences Inc. | 15.8 Million USD | -9804.312% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -14082.858% |
| Soligenix, Inc. | 7.27 Million USD | -21422.525% |
| Century Therapeutics, Inc. | 175.94 Million USD | -789.925% |
| Kura Oncology, Inc. | 51.66 Million USD | -2930.744% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1190.994% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -23573.682% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -519.856% |
| Autolus Therapeutics plc | 263.9 Million USD | -493.293% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -14837.445% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -1662.014% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -3238.542% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -343.734% |
| GRI Bio, Inc. | 2.69 Million USD | -57954.987% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -193300.693% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -4936.001% |
| IGM Biosciences, Inc. | 220.17 Million USD | -611.129% |
| INmune Bio, Inc. | 18.86 Million USD | -8201.044% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -510.476% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -5777.014% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -57497.835% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -47632.196% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -2578.544% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1528.285% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -491.438% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -90.242% |
| Verastem, Inc. | 71.18 Million USD | -2099.541% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -3083.958% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -3958.642% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -3099.834% |
| Histogen Inc. | 5.69 Million USD | -27383.641% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -35601.87% |
| Surrozen, Inc. | 8.14 Million USD | -19123.364% |
| Organovo Holdings, Inc. | 2.74 Million USD | -56877.547% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -498769.871% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -2684.538% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -9382.455% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -2963.896% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -189256.674% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1135.544% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -14379.4% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -937.679% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -59951.24% |
| Apollomics, Inc. | 14.15 Million USD | -10962.976% |
| Amarin Corporation plc | 279.58 Million USD | -460.02% |
| Turnstone Biologics Corp. | 14.14 Million USD | -10966.886% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -766.066% |
| Synaptogenix, Inc. | 5.52 Million USD | -28216.336% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -23452.091% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -820.441% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -18197.39% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -88994.642% |
| Exelixis, Inc. | 678.44 Million USD | -130.784% |
| Better Therapeutics, Inc. | 23.84 Million USD | -6467.163% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -854.454% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -163.5% |
| NLS Pharmaceutics AG | 10.68 Million USD | -14560.235% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -96335.549% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -3922.254% |
| Gritstone bio, Inc. | 125.91 Million USD | -1143.453% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -10568.731% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -30669.459% |
| Avid Bioservices, Inc. | 275.66 Million USD | -467.981% |
| Insmed Incorporated | 1.66 Billion USD | 5.778% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -20250.118% |
| MediWound Ltd. | 27.18 Million USD | -5659.161% |
| OmniAb, Inc. | 87.4 Million USD | -1691.468% |
| Alector, Inc. | 487.66 Million USD | -221.067% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -288.083% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -8397.927% |
| Zai Lab Limited | 240.17 Million USD | -551.912% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -148.508% |
| Aura Biosciences, Inc. | 29.22 Million USD | -5257.18% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1546.816% |
| Immunic, Inc. | 25.36 Million USD | -6072.118% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -2161.458% |
| Veracyte, Inc. | 93.71 Million USD | -1570.678% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -59737.167% |
| FibroGen, Inc. | 585.72 Million USD | -167.316% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -8907.323% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -239648.973% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -27585.521% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 79.55% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -18999.085% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -1763.492% |
| TG Therapeutics, Inc. | 169.08 Million USD | -826.009% |
| Galecto, Inc. | 5.89 Million USD | -26456.021% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -18800.809% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 40.202% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -5332.458% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -12305.855% |
| XBiotech Inc. | 8.39 Million USD | -18546.457% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -10568.731% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -2844.233% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -331.208% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -5724.07% |
| Theravance Biopharma, Inc. | 169 Million USD | -826.453% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -28.804% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -212.882% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -61.004% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -25861.121% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -110.101% |
| NexImmune, Inc. | 5.08 Million USD | -30696.057% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -421485.432% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -50820.989% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 77.969% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -30279.004% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -5854.754% |
| Ainos, Inc. | 7.39 Million USD | -21075.22% |
| Pluri Inc. | 34.11 Million USD | -4490.006% |
| Prothena Corporation plc | 135.01 Million USD | -1059.664% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -544.066% |
| Celularity Inc. | 102.92 Million USD | -1421.187% |
| Rallybio Corporation | 9.43 Million USD | -16493.292% |
| Cue Biopharma, Inc. | 24.44 Million USD | -6305.167% |
| MeiraGTx Holdings plc | 319.99 Million USD | -389.308% |
| Omeros Corporation | 403.25 Million USD | -288.279% |
| Humacyte, Inc. | 114.67 Million USD | -1265.351% |
| Immunocore Holdings plc | 228.15 Million USD | -586.254% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -32017.805% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1940.322% |
| Blueprint Medicines Corporation | 918.64 Million USD | -70.441% |
| CalciMedica, Inc. | 4.02 Million USD | -38771.475% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -8871.711% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -1724.514% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -463.637% |
| Pulmatrix, Inc. | 15.96 Million USD | -9708.576% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -9826.729% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -6263.257% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -524.28% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -2983.02% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -29.332% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -4826.354% |
| Nutriband Inc. | 1.07 Million USD | -145021.46% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -14625.317% |
| Vor Biopharma Inc. | 59.1 Million USD | -2549.132% |
| Roivant Sciences Ltd. | 773.95 Million USD | -102.305% |
| Evogene Ltd. | 17.99 Million USD | -8603.407% |
| ProKidney Corp. | 29.21 Million USD | -5259.197% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -2075.278% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 17.109% |
| CorMedix Inc. | 11.91 Million USD | -13038.152% |
| BioLineRx Ltd. | 50.7 Million USD | -2988.129% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -947.607% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -1670.381% |
| Atai Life Sciences N.V. | 49.16 Million USD | -3084.864% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -4926.09% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -8616.975% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1156.253% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -27592.66% |
| MediciNova, Inc. | 3.89 Million USD | -40134.4% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -8465.802% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -103988.574% |
| GeoVax Labs, Inc. | 3.51 Million USD | -44382.839% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -294.137% |
| Biomea Fusion, Inc. | 30.69 Million USD | -5001.802% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 42.473% |
| Mereo BioPharma Group plc | 15.96 Million USD | -9709.191% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -4918.246% |
| Absci Corporation | 58.3 Million USD | -2585.481% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8119.986% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -4783.485% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -2021.891% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -1689.768% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -4536.491% |
| Allakos Inc. | 74.79 Million USD | -1993.435% |
| Imunon, Inc. | 8.53 Million USD | -18254.802% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -6858.549% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1263.745% |
| BioAtla, Inc. | 48.98 Million USD | -3096.307% |
| NLS Pharmaceutics AG | 10.68 Million USD | -14560.235% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -56241.958% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1098.848% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -10914.724% |
| XOMA Corporation | 145.58 Million USD | -975.521% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -4550.952% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -2177.146% |
| aTyr Pharma, Inc. | 31.59 Million USD | -4855.353% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -2432.622% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -3382.137% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -3134.873% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -54455.505% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -19092.689% |
| Akari Therapeutics, Plc | 4.58 Million USD | -34056.697% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -8729.479% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 5.076% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -387548.425% |
| UroGen Pharma Ltd. | 243.52 Million USD | -542.955% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -387.638% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -56597.813% |
| Orgenesis Inc. | 35.53 Million USD | -4306.2% |
| Entera Bio Ltd. | 1.37 Million USD | -113441.914% |
| GH Research PLC | 6.7 Million USD | -23265.811% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -22925.632% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -8216.918% |
| Xencor, Inc. | 283.55 Million USD | -452.175% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -52341.843% |
| Replimune Group, Inc. | 113.21 Million USD | -1282.994% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -41573.966% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1412.357% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -387548.425% |
| Portage Biotech Inc. | 4.45 Million USD | -35085.236% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -103988.574% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -6692.811% |
| OncoCyte Corporation | 49.29 Million USD | -3076.078% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -37749.089% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -196235.35% |
| Purple Biotech Ltd. | 10 Million USD | -15549.605% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -26960.888% |
| scPharmaceuticals Inc. | 57.26 Million USD | -2634.397% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -12539.17% |
| HilleVax, Inc. | 78.9 Million USD | -1884.239% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -30904.812% |
| Tharimmune, Inc. | 1.81 Million USD | -86164.646% |
| Genprex, Inc. | 3.25 Million USD | -48014.411% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -5673.602% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -29803.419% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -759969.417% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -436589.927% |
| OKYO Pharma Limited | 7.42 Million USD | -20999.252% |
| Savara Inc. | 37.19 Million USD | -4109.892% |
| Curis, Inc. | 57.61 Million USD | -2617.738% |
| Daré Bioscience, Inc. | 26.32 Million USD | -5846.645% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -3894.263% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -108330.956% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -7420.741% |
| BeiGene, Ltd. | 2.23 Billion USD | 29.905% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -7254.428% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -496.708% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -7259.89% |
| Erasca, Inc. | 78.61 Million USD | -1891.761% |
| bluebird bio, Inc. | 424.62 Million USD | -268.736% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -238852.8% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 17.159% |
| DBV Technologies S.A. | 42.8 Million USD | -3558.278% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -238852.8% |
| Moderna, Inc. | 4.57 Billion USD | 65.754% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -22283.746% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -94449.698% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -9072.484% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -166.236% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1157.574% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -5606.684% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -4194.884% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -2714.313% |
| MacroGenics, Inc. | 154.2 Million USD | -915.351% |
| RenovoRx, Inc. | 4.46 Million USD | -34959.18% |
| Adicet Bio, Inc. | 37.12 Million USD | -4118.058% |
| Prime Medicine, Inc. | 60.78 Million USD | -2476.083% |
| Aditxt, Inc. | 28.53 Million USD | -5387.759% |
| Adagene Inc. | 45.16 Million USD | -3366.384% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -866382.753% |
| Quantum-Si incorporated | 26.63 Million USD | -5779.4% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -124.458% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -51363.432% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1261.978% |
| SciSparc Ltd. | 1.59 Million USD | -98065.705% |
| Vericel Corporation | 127.7 Million USD | -1126.062% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -28036.08% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -1734.323% |
| Generation Bio Co. | 171.63 Million USD | -812.278% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -13456.216% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -3643.021% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -519.61% |
| Invivyd, Inc. | 51.71 Million USD | -2927.755% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1602.32% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -23968.91% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1973.942% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -153253.869% |
| 2seventy bio, Inc. | 310.12 Million USD | -404.873% |
| Clene Inc. | 38.95 Million USD | -3919.776% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -4233.294% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -509.295% |
| GeoVax Labs, Inc. | 3.51 Million USD | -44382.839% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -722.936% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -12755.39% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -689.495% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -12739.432% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -3154.439% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -2863.121% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -323.341% |
| Evaxion Biotech A/S | 17.61 Million USD | -8787.44% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -872.94% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -922.119% |
| Trevena, Inc. | 48.26 Million USD | -3144.256% |
| Surrozen, Inc. | 8.14 Million USD | -19123.364% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -7150.489% |
| Cingulate Inc. | 10.36 Million USD | -15012.088% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -56836.109% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -4098.603% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -43556.33% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -11806.791% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -393.612% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -6201.03% |
| Clearmind Medicine Inc. | 3.61 Million USD | -43272.286% |
| Kronos Bio, Inc. | 54.2 Million USD | -2788.771% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -3228.323% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -6779.444% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -7701.021% |
| Statera Biopharma, Inc. | 22.67 Million USD | -6804.709% |
| ImmunityBio, Inc. | 1.09 Billion USD | -43.595% |
| Korro Bio, Inc. | 51.75 Million USD | -2925.473% |
| Kineta, Inc. | 7.22 Million USD | -21580.186% |
| BioVie Inc. | 9.7 Million USD | -16038.137% |
| Codexis, Inc. | 49.94 Million USD | -3034.872% |
| Celularity Inc. | 102.92 Million USD | -1421.187% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1526.797% |
| Celcuity Inc. | 51.45 Million USD | -2943.228% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -453483.492% |
| Cibus, Inc. | 206.11 Million USD | -659.638% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -3586.27% |
| IN8bio, Inc. | 8.77 Million USD | -17749.327% |
| Kodiak Sciences Inc. | 213.59 Million USD | -633.057% |
| Annexon, Inc. | 47.11 Million USD | -3223.025% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -1648.632% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1524.687% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -11337.965% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 39.857% |
| Eyenovia, Inc. | 19.78 Million USD | -7815.677% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -784.171% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -20284.624% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -6397.129% |
| Arcellx, Inc. | 339.75 Million USD | -360.849% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -13059.716% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -537.673% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -16272.927% |
| Moolec Science SA | 13.94 Million USD | -11127.702% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -3528.437% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -2998.518% |
| Royalty Pharma plc | 6.29 Billion USD | 75.137% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -3836.401% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -531731.213% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -63540.794% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -727.752% |
| Humacyte, Inc. | 114.67 Million USD | -1265.351% |
| 89bio, Inc. | 59.96 Million USD | -2511.182% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -5816.725% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -130814.967% |
| Genelux Corporation | 8.42 Million USD | -18495.523% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -22737.558% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1048.588% |
| Notable Labs, Ltd. | 4.42 Million USD | -35268.037% |
| Liquidia Corporation | 73.13 Million USD | -2040.806% |
| Mustang Bio, Inc. | 17.61 Million USD | -8786.673% |
| Immunovant, Inc. | 48.95 Million USD | -3098.331% |
| Quantum-Si incorporated | 26.63 Million USD | -5779.4% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -3979.262% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -50359.007% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -2019.851% |
| Acasti Pharma Inc. | 11.55 Million USD | -13448.006% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -6825.698% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -57497.835% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -4145.852% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -114788.079% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -25584.76% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -6204.582% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -6653.55% |
| PepGen Inc. | 34.63 Million USD | -4421.218% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -12793.141% |
| United Therapeutics Corporation | 1.18 Billion USD | -32.443% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -22319.001% |
| Solid Biosciences Inc. | 38.45 Million USD | -3971.306% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -18197.39% |
| Immuneering Corporation | 12 Million USD | -12938.78% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -498769.871% |
| Silo Pharma, Inc. | 1.56 Million USD | -99675.246% |
| Belite Bio, Inc | 4.21 Million USD | -37082.213% |
| XOMA Corporation | 145.58 Million USD | -975.521% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -64386.944% |
| Bionomics Limited | 10.15 Million USD | -15312.797% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -7185.575% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -6733.426% |
| uniQure N.V. | 624.01 Million USD | -150.913% |
| Cassava Sciences, Inc. | 14.19 Million USD | -10930.243% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -866382.753% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -820.029% |
| Forte Biosciences, Inc. | 3.66 Million USD | -42609.847% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -600761.53% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -23106.507% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -20284.624% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -8907.323% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -14715.888% |
| Altimmune, Inc. | 16.54 Million USD | -9365.83% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -153.477% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -6733.426% |
| Compugen Ltd. | 55.77 Million USD | -2707.249% |
| Peak Bio, Inc. | 20.75 Million USD | -7444.526% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1317.437% |
| Benitec Biopharma Inc. | 4.96 Million USD | -31454.676% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -891.962% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1982.825% |
| Zura Bio Limited | 21.29 Million USD | -7253.668% |
| PolyPid Ltd. | 17.46 Million USD | -8863.493% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -1293.022% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1982.825% |
| Instil Bio, Inc. | 99.8 Million USD | -1468.865% |
| argenx SE | 444.95 Million USD | -251.891% |
| Immunome, Inc. | 28.65 Million USD | -5363.546% |
| Verona Pharma plc | 58.84 Million USD | -2560.973% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -10718.372% |
| Shattuck Labs, Inc. | 14.85 Million USD | -10437.338% |
| CervoMed Inc. | 2.59 Million USD | -60219.553% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -32024.395% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -12193.836% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -14762.297% |
| Moolec Science SA | 13.94 Million USD | -11127.702% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -66712.047% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -2716.323% |
| Design Therapeutics, Inc. | 11.95 Million USD | -12995.877% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -12244.237% |
| NeurAxis, Inc. | 1.91 Million USD | -81758.685% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -3922.151% |
| Lumos Pharma, Inc. | 13.33 Million USD | -11643.366% |
| Achilles Therapeutics plc | 19.08 Million USD | -8103.191% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -10718.372% |
| 180 Life Sciences Corp. | 5.38 Million USD | -28964.085% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -6537.882% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -6779.444% |
| Nutriband Inc. | 1.07 Million USD | -145021.46% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -5017.142% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -10690.042% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -290.193% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -4721.676% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -11898.862% |
| Palisade Bio, Inc. | 2.73 Million USD | -57064.768% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -29706.644% |
| Beam Therapeutics Inc. | 478.38 Million USD | -227.298% |
| Neurogene Inc. | 36.54 Million USD | -4183.956% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -293.451% |
| AEON Biopharma, Inc. | 159.88 Million USD | -879.269% |
| Sesen Bio, Inc. | 30.98 Million USD | -4953.392% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -5931.135% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -20495.876% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -699.918% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -715.249% |
| Athira Pharma, Inc. | 30.05 Million USD | -5109.246% |
| Vaccinex, Inc. | 5.94 Million USD | -26250.438% |
| HCW Biologics Inc. | 15.05 Million USD | -10302.265% |
| XOMA Corporation | 145.58 Million USD | -975.521% |
| Nektar Therapeutics | 267.04 Million USD | -486.32% |
| Arvinas, Inc. | 644.6 Million USD | -142.901% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -8729.479% |
| Merus N.V. | 102.15 Million USD | -1432.773% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -969.862% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1546.071% |
| Rezolute, Inc. | 11.73 Million USD | -13243.642% |
| Clene Inc. | 38.95 Million USD | -3919.776% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -54888.902% |
| BeyondSpring Inc. | 48.26 Million USD | -3143.786% |
| Synlogic, Inc. | 32.89 Million USD | -4659.821% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -10614.727% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -95722.705% |
| Peak Bio, Inc. | 20.75 Million USD | -7444.526% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -2367.33% |
| Krystal Biotech, Inc. | 39.71 Million USD | -3842.547% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -315.709% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1472.521% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -361732.43% |
| MannKind Corporation | 721.36 Million USD | -117.053% |
| Ikena Oncology, Inc. | 22.33 Million USD | -6910.266% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -74959.588% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1426.214% |
| Gossamer Bio, Inc. | 249.14 Million USD | -528.441% |
| CohBar, Inc. | 1.03 Million USD | -151378.854% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -14548.171% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -8119.986% |
| Legend Biotech Corporation | 589.93 Million USD | -165.41% |
| Mural Oncology plc | 37.92 Million USD | -4028.198% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1080.481% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -68114.228% |
| Disc Medicine, Inc. | 22.87 Million USD | -6744.778% |
| Champions Oncology, Inc. | 28.03 Million USD | -5484.958% |
| REGENXBIO Inc. | 262.22 Million USD | -497.092% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -46508.483% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -12391.966% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -11557.136% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -7283.839% |
| Vaxart, Inc. | 34.02 Million USD | -4501.743% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -7579.252% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -5387.696% |
| Cellectis S.A. | 249.57 Million USD | -527.364% |
| Longeveron Inc. | 5.33 Million USD | -29237.512% |
| Repare Therapeutics Inc. | 41.81 Million USD | -3644.095% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 34.903% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -2493.664% |
| Revolution Medicines, Inc. | 262.39 Million USD | -496.708% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -74211.486% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -18051.438% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -13167.884% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -11049.633% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -72691.399% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 69.596% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1173.345% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -28036.08% |
| Veru Inc. | 32.81 Million USD | -4671.758% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -22694.337% |
| Cingulate Inc. | 10.36 Million USD | -15012.088% |
| Passage Bio, Inc. | 39.26 Million USD | -3887.935% |
| Context Therapeutics Inc. | 4.19 Million USD | -37253.279% |
| Exicure, Inc. | 8.54 Million USD | -18214.926% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -5206.164% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -14831.747% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -7003.775% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -860.661% |
| Nuvalent, Inc. | 31.82 Million USD | -4820.162% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -24512.304% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -2384.439% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -8598.572% |
| OmniAb, Inc. | 87.4 Million USD | -1691.468% |
| Anew Medical, Inc. | 8.24 Million USD | -18897.588% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -3989.266% |
| Lipocine Inc. | 2.63 Million USD | -59397.102% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -5859.74% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -3793.721% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -5777.014% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -1717.377% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -28889.872% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1792.205% |
| Ocugen, Inc. | 23.98 Million USD | -6428.554% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -3273.937% |
| Q32 Bio Inc. | 233.12 Million USD | -571.624% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -17170.494% |
| Alumis Inc. Common Stock | 53.5 Million USD | -2826.513% |
| Equillium, Inc. | 27.95 Million USD | -5500.54% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -657.891% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -27727.194% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -25429.939% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -895.222% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -2155.042% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -15597.929% |
| Dominari Holdings Inc. | 4.63 Million USD | -33680.863% |
| Edesa Biotech, Inc. | 1.84 Million USD | -84919.089% |
| vTv Therapeutics Inc. | 29.56 Million USD | -5195.576% |
| Bio-Techne Corporation | 744.34 Million USD | -110.353% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1141.678% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -354.555% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -3758.886% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -5307.131% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1595.261% |
| Nkarta, Inc. | 105.6 Million USD | -1382.711% |
| BioCardia, Inc. | 4.59 Million USD | -34012.048% |
| Iterum Therapeutics plc | 32.66 Million USD | -4693.776% |